Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inframat Advanced Materials (IAM) is a leading developer and manufacturer of high-performance nanostructured materials and advanced ceramic powders. The company specializes in the synthesis of biocompatible materials, such as nanostructured hydroxyapatite, which are utilized in orthopedic and dental implants to enhance osseointegration and mechanical stability. Beyond medical implants, IAM produces antimicrobial nanoparticles and specialty coatings designed for medical devices and healthcare environments. Their proprietary manufacturing processes allow for the creation of materials with tailored properties, serving the aerospace, energy, and life science sectors. IAM is recognized for its extensive research and development efforts, often supported by federal grants, to advance the application of nanotechnology in medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inframat Advanced Materials.